Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01829971
Title A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mirna Therapeutics, Inc.
Indications

liver cancer

chronic myeloid leukemia

lymphoma

Advanced Solid Tumor

myelodysplastic/myeloproliferative neoplasm

chronic lymphocytic leukemia

acute lymphoblastic leukemia

multiple myeloma

Therapies

MRX34

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.